Pacific Biosciences of California Inc (PACB)
1.97
+0.04
(+2.07%)
USD |
NASDAQ |
Dec 20, 16:00
1.97
0.00 (0.00%)
After-Hours: 20:00
Pacific Biosciences of California Enterprise Value: 1.002B for Dec. 20, 2024
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Baxter International Inc | 26.65B |
| Boston Scientific Corp | 139.72B |
| Globus Medical Inc | 10.99B |
| CeriBell Inc | 805.71M |
| Perspective Therapeutics Inc | -73.53M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -60.72M |
| Revenue (Quarterly) | 39.97M |
| Total Expenses (Quarterly) | 102.87M |
| EPS Diluted (Quarterly) | -0.22 |
| Gross Profit Margin (Quarterly) | 25.03% |
| Profit Margin (Quarterly) | -151.9% |
| Earnings Yield | -74.11% |
| Normalized Earnings Yield | -56.32 |